Metraipolis › archive › dc_14f3c0ccc8dc

Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines — Europe PMC PMID:28670885

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/28670885
DOI
10.22034/apjcp.2017.18.6.1655
License (as archived)
solo-consultazione
Archived
2026-11-08T19:23:17.570Z
SHA-256 of the archived text
cadee1d1764770d3f9f899e1596248725b93ea61bbcb5eed65c712e0ebb5106e
Stable URL of this page
https://metraipolis.com/documento/dc_14f3c0ccc8dc

How to cite

Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines — Europe PMC PMID:28670885 — Europe PMC (en), https://europepmc.org/article/MED/28670885 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_14f3c0ccc8dc (Metraipolis archive dc_14f3c0ccc8dc, sha256 cadee1d1764770d3f9f899e1596248725b93ea61bbcb5eed65c712e0ebb5106e)
BibTeX
@misc{dc14f3c0ccc8dc,
  title = {Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines — Europe PMC PMID:28670885},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/28670885},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_14f3c0ccc8dc; sha256 cadee1d1764770d3f9f899e1596248725b93ea61bbcb5eed65c712e0ebb5106e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28670885. Agents can read the archived copy with the MCP tool read_document.